Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells.

Autor: Müller, Tina, Uherek, Christoph, Maki, Guitta, Kai UweChow, Schimpf, Annemarie, Klingemann, Hans-Georg, Tonn, Torsten, Wels, Winfried S.

Publikováno v: Cancer Immunology, Immunotherapy; Mar2008, Vol. 57 Issue 3, p411-423, 13p, 1 Color Photograph, 1 Chart, 6 Graphs